Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IDP-121 |
Synonyms | |
Therapy Description |
IDP-121 is peptide that targets Myc, potentially leading to decreased tumor cell viability and inhibition of tumor growth (Cancer Res (2021) 81 (13_Supplement): 1291). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IDP-121 | IDP 121|IDP121 | c-MYC Inhibitor 12 | IDP-121 is peptide that targets Myc, potentially leading to decreased tumor cell viability and inhibition of tumor growth (Cancer Res (2021) 81 (13_Supplement): 1291). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05908409 | Phase Ib/II | IDP-121 | A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies | Recruiting | ESP | 0 |